GB981372A - Pharmaceutical formulations for oral administration to animals - Google Patents

Pharmaceutical formulations for oral administration to animals

Info

Publication number
GB981372A
GB981372A GB1568860A GB1568860A GB981372A GB 981372 A GB981372 A GB 981372A GB 1568860 A GB1568860 A GB 1568860A GB 1568860 A GB1568860 A GB 1568860A GB 981372 A GB981372 A GB 981372A
Authority
GB
United Kingdom
Prior art keywords
sorbitol
polyoxyethylated
wafer
animals
humectant
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB1568860A
Inventor
Leslie John Gower
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Ltd
Original Assignee
Pfizer Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Ltd filed Critical Pfizer Ltd
Priority to GB1568860A priority Critical patent/GB981372A/en
Publication of GB981372A publication Critical patent/GB981372A/en
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays

Abstract

A solid wafer formulation, which readily adheres to the tongue or buccal mucosa of animals, comprises a physiologically active substance, a solid non-toxic adhesive and a non-toxic humectant and plasticizer. Preferably the wafers have a surface area greater than 300 square millilitres and a thickness from 0,2 to 1,0 mm. A wafer for piglets is prepared by drying a sheet of paste containing iron powder and copper powder suspended in an aqueous solution of sorbitol and sodium carboxymethylcellulose. In a second example, the active substance is calcium dioxytetracyclinne and the wafer is prepared from sodium carboxymethylcellulose, sorbitol and polyoxyethylated sorbitol. Other adhesives are hydroxyethylcellulose, a water-soluble polyethylene resin, gum tragacanth, gum arabic, gum Karaya, sodium silicate, hydrated aluminium silicate, isinglass, agar-agar, water-soluble alginate, gelatine, casein and albumen. The humectant and plasticizer may by glycerol, propylene glycol, dipropylene glycol, polyoxyethylated sorbitol, polyoxyethylated glycol, polyoxyethylated glycerol, a -methylglycerol, corn syrup or propylene glycol glucoside.
GB1568860A 1960-05-04 1960-05-04 Pharmaceutical formulations for oral administration to animals Expired GB981372A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
GB1568860A GB981372A (en) 1960-05-04 1960-05-04 Pharmaceutical formulations for oral administration to animals

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB1568860A GB981372A (en) 1960-05-04 1960-05-04 Pharmaceutical formulations for oral administration to animals

Publications (1)

Publication Number Publication Date
GB981372A true GB981372A (en) 1965-01-27

Family

ID=10063653

Family Applications (1)

Application Number Title Priority Date Filing Date
GB1568860A Expired GB981372A (en) 1960-05-04 1960-05-04 Pharmaceutical formulations for oral administration to animals

Country Status (1)

Country Link
GB (1) GB981372A (en)

Cited By (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4231369A (en) 1977-05-24 1980-11-04 Coloplast International A/S Sealing material for ostomy devices
EP0106107A2 (en) * 1982-09-10 1984-04-25 Teikoku Seiyaku Kabushiki Kaisha Sheet-shape adhesive preparation
GB2133284A (en) * 1983-01-07 1984-07-25 English Grains Limited Resilient pharmaceutical unit for treating mouth ulcers
EP0159602A2 (en) * 1984-04-11 1985-10-30 Ici Australia Limited Compositions and methods for the therapeutic treatment of trace element deficiencies in ruminant animals
EP0245952A2 (en) * 1986-04-11 1987-11-19 Reckitt And Colman Products Limited Buccal tablet comprising etorphine or a salt thereof
EP0306454A2 (en) * 1987-08-31 1989-03-08 Warner-Lambert Company Tablets having improved bioadhesion to mucous membranes
WO2000019987A1 (en) * 1998-10-02 2000-04-13 3M Innovative Properties Company Mucosal originated drug delivery systems and animal applications
EP1516615A2 (en) * 1994-08-04 2005-03-23 Quadrant Drug Delivery Limited Solid delivery systems for controlled release of molecules incorporated therein and methods of making same
US7001609B1 (en) 1998-10-02 2006-02-21 Regents Of The University Of Minnesota Mucosal originated drug delivery systems and animal applications
DE102005015128A1 (en) * 2005-03-31 2006-10-05 Lts Lohmann Therapie-Systeme Ag Wafers containing steroid hormones
WO2006133134A2 (en) 2005-06-03 2006-12-14 Prezacor, Inc. Compositions comprising elemental metals and uses therefor
US7579019B2 (en) 1996-10-18 2009-08-25 Arius Two, Inc. Pharmaceutical carrier device suitable for delivery of pharmaceutical compounds to mucosal surfaces
US8703177B2 (en) 2011-08-18 2014-04-22 Biodelivery Sciences International, Inc. Abuse-resistant mucoadhesive devices for delivery of buprenorphine
AU2012216851B2 (en) * 2005-06-03 2015-05-07 Prezacor, Inc. Compositions comprising elemental metals and uses therefor
US9597288B2 (en) 2006-07-21 2017-03-21 Biodelivery Sciences International, Inc. Transmucosal delivery devices with enhanced uptake
US9901539B2 (en) 2011-12-21 2018-02-27 Biodelivery Sciences International, Inc. Transmucosal drug delivery devices for use in chronic pain relief
US10905894B2 (en) 2013-03-15 2021-02-02 Prezacor, Inc. Therapeutic bioelectromagnetic fields, pain relief devices, and related methods

Cited By (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4231369A (en) 1977-05-24 1980-11-04 Coloplast International A/S Sealing material for ostomy devices
US4767787A (en) * 1982-09-10 1988-08-30 Kaken Pharmaceutical Co., Ltd. Sheet-shape adhesive preparation
EP0106107A2 (en) * 1982-09-10 1984-04-25 Teikoku Seiyaku Kabushiki Kaisha Sheet-shape adhesive preparation
EP0106107A3 (en) * 1982-09-10 1985-09-04 Teikoku Seiyaku Kabushiki Kaisha Sheet-shape adhesive preparation
GB2133284A (en) * 1983-01-07 1984-07-25 English Grains Limited Resilient pharmaceutical unit for treating mouth ulcers
EP0159602A2 (en) * 1984-04-11 1985-10-30 Ici Australia Limited Compositions and methods for the therapeutic treatment of trace element deficiencies in ruminant animals
EP0159602A3 (en) * 1984-04-11 1987-01-21 Ici Australia Limited Compositions and methods for the therapeutic treatment of trace element deficiencies in ruminant animals
EP0245952A2 (en) * 1986-04-11 1987-11-19 Reckitt And Colman Products Limited Buccal tablet comprising etorphine or a salt thereof
EP0245952A3 (en) * 1986-04-11 1988-02-10 Reckitt And Colman Products Limited Buccal tablet comprising etorphine or a salt thereof
US4829056A (en) * 1986-04-11 1989-05-09 Reckitt & Colman Products Limited Buccal tablet comprising etorphine or a salt thereof
EP0306454A2 (en) * 1987-08-31 1989-03-08 Warner-Lambert Company Tablets having improved bioadhesion to mucous membranes
EP0306454A3 (en) * 1987-08-31 1989-05-10 Warner-Lambert Company Tablets having improved bioadhesion to mucous membranes
EP1516615A2 (en) * 1994-08-04 2005-03-23 Quadrant Drug Delivery Limited Solid delivery systems for controlled release of molecules incorporated therein and methods of making same
EP1516615A3 (en) * 1994-08-04 2007-10-31 Quadrant Drug Delivery Limited Solid delivery systems for controlled release of molecules incorporated therein and methods of making same
US7579019B2 (en) 1996-10-18 2009-08-25 Arius Two, Inc. Pharmaceutical carrier device suitable for delivery of pharmaceutical compounds to mucosal surfaces
WO2000019987A1 (en) * 1998-10-02 2000-04-13 3M Innovative Properties Company Mucosal originated drug delivery systems and animal applications
AU768040B2 (en) * 1998-10-02 2003-11-27 Entrega Labs, Llc Mucosal originated drug delivery systems and animal applications
US7001609B1 (en) 1998-10-02 2006-02-21 Regents Of The University Of Minnesota Mucosal originated drug delivery systems and animal applications
DE102005015128A1 (en) * 2005-03-31 2006-10-05 Lts Lohmann Therapie-Systeme Ag Wafers containing steroid hormones
US9763960B2 (en) 2005-03-31 2017-09-19 Lts Lohmann Theraple-Systeme Ag Wafer comprising steroid hormones
DE102005015128B4 (en) * 2005-03-31 2008-12-11 Bayer Schering Pharma Aktiengesellschaft Wafers containing steroid hormones
WO2006133134A2 (en) 2005-06-03 2006-12-14 Prezacor, Inc. Compositions comprising elemental metals and uses therefor
US9173900B2 (en) 2005-06-03 2015-11-03 Prezacor, Inc. Compositions comprising elemental metals
EP1904297A2 (en) * 2005-06-03 2008-04-02 Prezacor, Inc. Compositions comprising elemental metals and uses therefor
EP2508341A1 (en) * 2005-06-03 2012-10-10 Prezacor, Inc. Compositions comprising elemental metals and uses therefor
JP2013006872A (en) * 2005-06-03 2013-01-10 Prezacor Inc Composition containing elemental metal, and use of the same
US10195148B2 (en) 2005-06-03 2019-02-05 Prezacor, Inc. Pain relieving compositions comprising elemental metals
AU2012216851B2 (en) * 2005-06-03 2015-05-07 Prezacor, Inc. Compositions comprising elemental metals and uses therefor
EP1904297A4 (en) * 2005-06-03 2009-02-18 Prezacor Inc Compositions comprising elemental metals and uses therefor
JP2008545758A (en) * 2005-06-03 2008-12-18 プレザーコール， インコーポレイテッド Compositions containing elemental metals and uses thereof
US9655843B2 (en) 2006-07-21 2017-05-23 Biodelivery Sciences International, Inc. Transmucosal delivery devices with enhanced uptake
US9597288B2 (en) 2006-07-21 2017-03-21 Biodelivery Sciences International, Inc. Transmucosal delivery devices with enhanced uptake
US8703177B2 (en) 2011-08-18 2014-04-22 Biodelivery Sciences International, Inc. Abuse-resistant mucoadhesive devices for delivery of buprenorphine
US9901539B2 (en) 2011-12-21 2018-02-27 Biodelivery Sciences International, Inc. Transmucosal drug delivery devices for use in chronic pain relief
US10905894B2 (en) 2013-03-15 2021-02-02 Prezacor, Inc. Therapeutic bioelectromagnetic fields, pain relief devices, and related methods

Similar Documents

Publication Publication Date Title
GB981372A (en) Pharmaceutical formulations for oral administration to animals
US4594240A (en) Sheet-shape adhesive preparation
US4517173A (en) Mucous membrane-adhering film preparation and process for its preparation
US3429308A (en) Method for administering drugs from a vehicle adhering by suction to the parabuccal cavity mucous membrane
IT8348149A0 (en) PHARMACEUTICAL FORMULATION OF CLOMETACIN FOR ORAL ADMINISTRATION AND PREPARATION PROCEDURE
FI820467L (en) PHARMACEUTICAL COMPOSITION SOM FRIGOERS KONTINUERLIGT
SG52784G (en) Powdery pharmaceutical composition and powdery preparation for application to the nasal mucosa,and method for administration thereof
NO178095C (en) Process for the preparation of a wrapped pharmaceutical retarding composition
HU195617B (en) Process for producing pharmaceutical compositions containing 2-/4-isobutyl-phenyl6-propionic acid
ATE33937T1 (en) NYSTATIN lozenge.
ATE501T1 (en) COLLOID AQUEOUS COMPOSITIONS FOR PHARMACEUTICAL PURPOSES AND THEIR PRODUCTION.
BE901328A (en) PHARMACEUTICAL COMPOSITION WITH CONTROLLED ABSORPTION.
NO168628C (en) PROCEDURE FOR THE PREPARATION OF PERORAL PREPARATIONS CONTAINING ANTIDIABETIC SULPHONYLUREA COMPOUNDS AND / OR BENZO ACID DERIVATIVES
IT8220758A1 (en) Pharmaceutical products in delayed form and the procedure for obtaining them
EP0009609A3 (en) Adjuvant for promoting absorption of therapeutically active substances through the digestive tract, pharmaceutical composition comprising said adjuvant and process for preparing said pharmaceutical composition; enamine derivatives
MX9100246A (en) PHARMACEUTICAL PREPARATION IN THE FORM OF TABLETS OR Dragees CONTAINING SULCRALPHATE AND PROCEDURE FOR THE PREPARATION
IE42950L (en) X-ray contrast preparations
JPS6125687B2 (en)
JPH057368B2 (en)
NO179094C (en) Method of preparing a pharmaceutical composition for application to the mucosa
BE876296A (en) PHARMACEUTICAL COMPOSITIONS CONTAINING PROSTAGLANDINS
GB2021409A (en) Pharmaceutical composition
JPS5441320A (en) Slow release preparation and its manufacturing
JPS57118511A (en) Gradually releasing preparation
JPS55118414A (en) Prolonged release drug and its preparation